China Opioids Drug Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Opioids Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Opioids Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Opioids Drug Overall Market Size
2.1 China Opioids Drug Market Size: 2021 VS 2027
2.2 China Opioids Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 China Opioids Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Opioids Drug Players in China Market
3.2 Top China Opioids Drug Companies Ranked by Revenue
3.3 China Opioids Drug Revenue by Companies
3.4 China Opioids Drug Sales by Companies
3.5 China Opioids Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Opioids Drug Companies in China Market, by Revenue in 2020
3.7 Manufacturers Opioids Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Opioids Drug Players in China Market
3.8.1 List of Tier 1 Opioids Drug Companies in China
3.8.2 List of Tier 2 and Tier 3 Opioids Drug Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Opioids Drug Market Size Markets, 2021 & 2027
4.1.2 Oxycodone
4.1.3 Hydromorphone
4.1.4 Codeine
4.1.5 Fentanyl
4.2 By Type - China Opioids Drug Revenue & Forecasts
4.2.1 By Type - China Opioids Drug Revenue, 2016-2021
4.2.2 By Type - China Opioids Drug Revenue, 2022-2027
4.2.3 By Type - China Opioids Drug Revenue Market Share, 2016-2027
4.3 By Type - China Opioids Drug Sales & Forecasts
4.3.1 By Type - China Opioids Drug Sales, 2016-2021
4.3.2 By Type - China Opioids Drug Sales, 2022-2027
4.3.3 By Type - China Opioids Drug Sales Market Share, 2016-2027
4.4 By Type - China Opioids Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Opioids Drug Market Size, 2021 & 2027
5.1.2 Pain Relief
5.1.3 Anesthesia
5.1.4 Others
5.2 By Application - China Opioids Drug Revenue & Forecasts
5.2.1 By Application - China Opioids Drug Revenue, 2016-2021
5.2.2 By Application - China Opioids Drug Revenue, 2022-2027
5.2.3 By Application - China Opioids Drug Revenue Market Share, 2016-2027
5.3 By Application - China Opioids Drug Sales & Forecasts
5.3.1 By Application - China Opioids Drug Sales, 2016-2021
5.3.2 By Application - China Opioids Drug Sales, 2022-2027
5.3.3 By Application - China Opioids Drug Sales Market Share, 2016-2027
5.4 By Application - China Opioids Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Overview
6.1.3 Teva Opioids Drug Sales and Revenue in China Market (2016-2021)
6.1.4 Teva Opioids Drug Product Description
6.1.5 Teva Recent Developments
6.2 Purdue Pharma
6.2.1 Purdue Pharma Corporation Information
6.2.2 Purdue Pharma Overview
6.2.3 Purdue Pharma Opioids Drug Sales and Revenue in China Market (2016-2021)
6.2.4 Purdue Pharma Opioids Drug Product Description
6.2.5 Purdue Pharma Recent Developments
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Overview
6.3.3 Mallinckrodt Opioids Drug Sales and Revenue in China Market (2016-2021)
6.3.4 Mallinckrodt Opioids Drug Product Description
6.3.5 Mallinckrodt Recent Developments
6.4 Amneal Pharma
6.4.1 Amneal Pharma Corporation Information
6.4.2 Amneal Pharma Overview
6.4.3 Amneal Pharma Opioids Drug Sales and Revenue in China Market (2016-2021)
6.4.4 Amneal Pharma Opioids Drug Product Description
6.4.5 Amneal Pharma Recent Developments
6.5 Collegium
6.5.1 Collegium Corporation Information
6.5.2 Collegium Overview
6.5.3 Collegium Opioids Drug Sales and Revenue in China Market (2016-2021)
6.5.4 Collegium Opioids Drug Product Description
6.5.5 Collegium Recent Developments
6.6 J&J
6.6.1 J&J Corporation Information
6.6.2 J&J Overview
6.6.3 J&J Opioids Drug Sales and Revenue in China Market (2016-2021)
6.6.4 J&J Opioids Drug Product Description
6.6.5 J&J Recent Developments
6.7 Endo
6.7.1 Endo Corporation Information
6.7.2 Endo Overview
6.7.3 Endo Opioids Drug Sales and Revenue in China Market (2016-2021)
6.7.4 Endo Opioids Drug Product Description
6.7.5 Endo Recent Developments
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Overview
6.8.3 Pfizer Opioids Drug Sales and Revenue in China Market (2016-2021)
6.8.4 Pfizer Opioids Drug Product Description
6.8.5 Pfizer Recent Developments
6.9 INSYS
6.9.1 INSYS Corporation Information
6.9.2 INSYS Overview
6.9.3 INSYS Opioids Drug Sales and Revenue in China Market (2016-2021)
6.9.4 INSYS Opioids Drug Product Description
6.9.5 INSYS Recent Developments
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Overview
6.10.3 Mylan Opioids Drug Sales and Revenue in China Market (2016-2021)
6.10.4 Mylan Opioids Drug Product Description
6.10.5 Mylan Recent Developments
6.11 Hikma
6.11.1 Hikma Corporation Information
6.11.2 Hikma Overview
6.11.3 Hikma Opioids Drug Sales and Revenue in China Market (2016-2021)
6.11.4 Hikma Opioids Drug Product Description
6.11.5 Hikma Recent Developments
6.12 Egalet
6.12.1 Egalet Corporation Information
6.12.2 Egalet Overview
6.12.3 Egalet Opioids Drug Sales and Revenue in China Market (2016-2021)
6.12.4 Egalet Opioids Drug Product Description
6.12.5 Egalet Recent Developments
7 China Opioids Drug Production Capacity, Analysis
7.1 China Opioids Drug Production Capacity, 2016-2027
7.2 Opioids Drug Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Opioids Drug Supply Chain Analysis
9.1 Opioids Drug Industry Value Chain
9.2 Opioids Drug Upstream Market
9.3 Opioids Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Opioids Drug Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Opioids Drug in China Market
Table 2. Top Opioids Drug Players in China Market, Ranking by Revenue (2019)
Table 3. China Opioids Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Opioids Drug Revenue Share by Companies, 2016-2021
Table 5. China Opioids Drug Sales by Companies, (M Units), 2016-2021
Table 6. China Opioids Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Opioids Drug Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Opioids Drug Product Type
Table 9. List of Tier 1 Opioids Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Opioids Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oxycodone
Table 12. Major Manufacturers of Hydromorphone
Table 13. By Type - China Opioids Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Opioids Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Opioids Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Opioids Drug Sales (M Units), 2016-2021
Table 17. By Type - China Opioids Drug Sales (M Units), 2022-2027
Table 18. By Application - China Opioids Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Opioids Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Opioids Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Opioids Drug Sales (M Units), 2016-2021
Table 22. By Application - China Opioids Drug Sales (M Units), 2022-2027
Table 23. Teva Corporation Information
Table 24. Teva Description and Major Businesses
Table 25. Teva Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Teva Opioids Drug Product
Table 27. Teva Recent Developments
Table 28. Purdue Pharma Corporation Information
Table 29. Purdue Pharma Description and Major Businesses
Table 30. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Purdue Pharma Opioids Drug Product
Table 32. Purdue Pharma Recent Developments
Table 33. Mallinckrodt Corporation Information
Table 34. Mallinckrodt Description and Major Businesses
Table 35. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Mallinckrodt Opioids Drug Product
Table 37. Mallinckrodt Recent Developments
Table 38. Amneal Pharma Corporation Information
Table 39. Amneal Pharma Description and Major Businesses
Table 40. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Amneal Pharma Opioids Drug Product
Table 42. Amneal Pharma Recent Developments
Table 43. Collegium Corporation Information
Table 44. Collegium Description and Major Businesses
Table 45. Collegium Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Collegium Opioids Drug Product
Table 47. Collegium Recent Developments
Table 48. J&J Corporation Information
Table 49. J&J Description and Major Businesses
Table 50. J&J Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. J&J Opioids Drug Product
Table 52. J&J Recent Developments
Table 53. Endo Corporation Information
Table 54. Endo Description and Major Businesses
Table 55. Endo Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Endo Opioids Drug Product
Table 57. Endo Recent Developments
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Major Businesses
Table 60. Pfizer Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Pfizer Opioids Drug Product
Table 62. Pfizer Recent Developments
Table 63. INSYS Corporation Information
Table 64. INSYS Description and Major Businesses
Table 65. INSYS Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. INSYS Opioids Drug Product
Table 67. INSYS Recent Developments
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Major Businesses
Table 70. Mylan Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Mylan Opioids Drug Product
Table 72. Mylan Recent Developments
Table 73. Hikma Corporation Information
Table 74. Hikma Description and Major Businesses
Table 75. Hikma Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Hikma Opioids Drug Product
Table 77. Hikma Recent Developments
Table 78. Egalet Corporation Information
Table 79. Egalet Description and Major Businesses
Table 80. Egalet Opioids Drug Sales (M Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. Egalet Opioids Drug Product
Table 82. Egalet Recent Developments
Table 83. Opioids Drug Production Capacity (M Units) of Key Manufacturers in China Market, 2019-2021 (M Units)
Table 84. China Opioids Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 85. Opioids Drug Market Opportunities & Trends in China Market
Table 86. Opioids Drug Market Drivers in China Market
Table 87. Opioids Drug Market Restraints in China Market
Table 88. Opioids Drug Raw Materials
Table 89. Opioids Drug Raw Materials Suppliers in China Market
Table 90. Typical Opioids Drug Downstream
Table 91. Opioids Drug Downstream Clients in China Market
Table 92. Opioids Drug Distributors and Sales Agents in China Market
List of FiguresFigure 1. Opioids Drug Product Picture
Figure 2. Opioids Drug Segment by Type
Figure 3. Opioids Drug Segment by Application
Figure 4. China Opioids Drug Market Overview: 2020
Figure 5. China Opioids Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Opioids Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Opioids Drug Sales in China Market: 2016-2027 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Opioids Drug Revenue in 2020
Figure 9. Oxycodone Product Picture
Figure 10. Hydromorphone Product Picture
Figure 11. Codeine Product Picture
Figure 12. Fentanyl Product Picture
Figure 13. By Type - China Opioids Drug Sales Market Share, 2016-2027
Figure 14. By Type - China Opioids Drug Revenue Market Share, 2016-2027
Figure 15. By Type - China Opioids Drug Price (USD/Unit), 2016-2027
Figure 16. Pain Relief
Figure 17. Anesthesia
Figure 18. Others
Figure 19. By Application - China Opioids Drug Sales Market Share, 2016-2027
Figure 20. By Application - China Opioids Drug Revenue Market Share, 2016-2027
Figure 21. By Application - China Opioids Drug Price (USD/Unit), 2016-2027
Figure 22. Teva Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Purdue Pharma Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Mallinckrodt Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Amneal Pharma Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Collegium Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. J&J Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Endo Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Pfizer Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. INSYS Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Mylan Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Hikma Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Egalet Opioids Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. China Opioids Drug Production Capacity (M Units), 2016-2027
Figure 35. Opioids Drug Industry Value Chain
Figure 36. Marketing Channels